Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Anti-CD7 CAR T Cells by ICell Gene Therapeutics for T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval
Anti-CD7 CAR T Cells is under clinical development by ICell Gene Therapeutics and currently in Phase I for T-Cell Acute...
Anti-CD7 CAR T Cells by ICell Gene Therapeutics for Acute Lymphoblastic Lymphoma: Likelihood of Approval
Anti-CD7 CAR T Cells is under clinical development by ICell Gene Therapeutics and currently in Phase I for Acute Lymphoblastic...
Anti-CD7 CAR T Cells by ICell Gene Therapeutics for Non-Hodgkin Lymphoma: Likelihood of Approval
Anti-CD7 CAR T Cells is under clinical development by ICell Gene Therapeutics and currently in Phase I for Non-Hodgkin Lymphoma....